0001209191-15-039126.txt : 20150505 0001209191-15-039126.hdr.sgml : 20150505 20150505210025 ACCESSION NUMBER: 0001209191-15-039126 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150501 FILED AS OF DATE: 20150505 DATE AS OF CHANGE: 20150505 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Receptos, Inc. CENTRAL INDEX KEY: 0001463729 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264190792 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10835 ROAD TO THE CURE STREET 2: SUITE 205 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-652-5700 MAIL ADDRESS: STREET 1: 10835 ROAD TO THE CURE STREET 2: SUITE 205 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Receptos, Inc. (f.k.a. Receptor Pharmaceuticals Inc.) DATE OF NAME CHANGE: 20090522 FORMER COMPANY: FORMER CONFORMED NAME: Receptor Pharmaceuticals Inc. DATE OF NAME CHANGE: 20090507 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Christian Waage CENTRAL INDEX KEY: 0001553179 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35900 FILM NUMBER: 15834874 MAIL ADDRESS: STREET 1: RECEPTOS, INC. STREET 2: 10835 ROAD TO THE CURE, SUITE 205 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-05-01 0 0001463729 Receptos, Inc. RCPT 0001553179 Christian Waage 3033 SCIENCE PARK, SUITE 300 SAN DIEGO CA 92121 0 1 0 0 SVP & General Counsel Common Stock 2015-05-01 4 M 0 12500 22.65 A 12500 D Common Stock 2015-05-01 4 S 0 12500 154.46 D 0 D Employee Stock Option (right to buy) 22.65 2015-05-01 4 M 0 12500 0.00 D 2023-11-24 Common Stock 12500 112500 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.50 to $156.95 per share, inclusive. The reporting person undertakes to provide to Receptos, Inc., any security holder of Receptos, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The option, representing a right to purchase a total of 150,000 shares, became exercisable as follows: 25% on the one-year anniversary of November 25, 2013 and 1/48th of the shares vest each month thereafter for the remaining three years. The option is subject to vesting acceleration in the event of certain corporate or change of control transactions. /s/ Christian Waage 2015-05-05